LSTA | Lisata Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.03 - 3.17
52 Week Range	2.1900 - 3.83
Beta	1.36
Implied Volatility	507.94%
IV Rank	N/A
Day's Volume	4,574
Average Volume	15,748
Shares Outstanding	8,394,900
Market Cap	26,276,037
Sector	Healthcare
Industry	Biotechnology
IPO Date	1999-03-01

Valuation
Profitability
Growth
Health
P/E Ratio	-1.25
Forward P/E Ratio	N/A
EPS	-2.51
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	25
Country	USA
Website	LSTA

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

LSTA's peers: IMNN, LIXT, HSTO, KA, RZLT, CYT, XOMAO, PTIX, TPST, PULM, ONTX, CBIO, BPTH, MBRX, ALPN, ANTX, AMPE, GLUE, CADL, TOVX

*Chart delayed

Analyzing fundamentals for LSTA we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see LSTA Fundamentals page.

Watching at LSTA technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on LSTA Technicals page.